Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 159 participants.
Also called NCT02217501
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 159 participants
- Registry
-
NCT02217501
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02217501. Randomized; no masking; primary purpose treatment. Start 2015-11 (registry gives no type); primary completion 2020-01-30 (actual). Results posted on 2021-02-21.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities
- Acronym
- ASPIRE
- Condition
- Peripheral Arterial Disease
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Acetylsalicylic acid (ASA)
- Lead sponsor
- University of Texas Southwestern Medical Center
Record details
- Record id
cardio:ct-nct02217501- Content hash
185eddab7fe2e5af4619523155dfa9b77e44e5099c1971ead69c1a5b51d1432f